Activation-induced Tumor Necrosis Factor Receptor-associated Factor 3 (Traf3) Alternative Splicing Controls the Noncanonical Nuclear Factor κB Pathway and Chemokine Expression in Human T Cells
Open Access
- 1 May 2014
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 289 (19) , 13651-13660
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Control of alternative splicing in immune responses: many regulators, many predictions, much still to learnImmunological Reviews, 2013
- OTUD7B controls non-canonical NF-κB activation through deubiquitination of TRAF3Nature, 2013
- Evolutionary Dynamics of Gene and Isoform Regulation in Mammalian TissuesScience, 2012
- Complex changes in alternative pre-mRNA splicing play a central role in the epithelial-to-mesenchymal transition (EMT)Seminars in Cancer Biology, 2012
- Tissue-Specific Alternative Splicing Remodels Protein-Protein Interaction NetworksMolecular Cell, 2012
- The two NF-κB activation pathways and their role in innate and adaptive immunityTrends in Immunology, 2004
- Mechanisms of Alternative Pre-Messenger RNA SplicingAnnual Review of Biochemistry, 2003
- Essential Role of Nuclear Factor (NF)-κB–Inducing Kinase and Inhibitor of κb (Iκb) Kinase α in Nf-κb Activation through Lymphotoxin β Receptor, but Not through Tumor Necrosis Factor Receptor IJournal of Experimental Medicine, 2001
- A chemokine-driven positive feedback loop organizes lymphoid folliclesNature, 2000
- A Model System for Activation-Induced Alternative Splicing of CD45 Pre-mRNA in T Cells Implicates Protein Kinase C and RasMolecular and Cellular Biology, 2000